Clinical Trials · NCT05822609
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Washington
- Enrollment
- 60
- Start date
- Apr 2024
- Locations
- 4 sites, United States, Canada
- Primary endpoint
- Change in urine albumin excretion